128 related articles for article (PubMed ID: 15033688)
1. p73, the "assistant" guardian of the genome?
Melino G
Ann N Y Acad Sci; 2003 Dec; 1010():9-15. PubMed ID: 15033688
[TBL] [Abstract][Full Text] [Related]
2. p73.
Davis PK; Dowdy SF
Int J Biochem Cell Biol; 2001 Oct; 33(10):935-9. PubMed ID: 11470228
[TBL] [Abstract][Full Text] [Related]
3. p53 mutations and resistance to chemotherapy: A stab in the back for p73.
Soussi T
Cancer Cell; 2003 Apr; 3(4):303-5. PubMed ID: 12726854
[TBL] [Abstract][Full Text] [Related]
4. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
[TBL] [Abstract][Full Text] [Related]
5. p73 is transcriptionally regulated by DNA damage, p53, and p73.
Chen X; Zheng Y; Zhu J; Jiang J; Wang J
Oncogene; 2001 Feb; 20(6):769-74. PubMed ID: 11314010
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
Zaika AI; Kovalev S; Marchenko ND; Moll UM
Cancer Res; 1999 Jul; 59(13):3257-63. PubMed ID: 10397274
[TBL] [Abstract][Full Text] [Related]
7. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner.
Zhu J; Nozell S; Wang J; Jiang J; Zhou W; Chen X
Oncogene; 2001 Jul; 20(30):4050-7. PubMed ID: 11494133
[TBL] [Abstract][Full Text] [Related]
8. [p53 mutations and resistance to chemotherapy: a stab in the back for p73?].
Soussi T
Bull Cancer; 2003 May; 90(5):383-6. PubMed ID: 12850759
[TBL] [Abstract][Full Text] [Related]
9. p53 and p73: seeing double?
Soengas MS; Lowe SW
Nat Genet; 2000 Dec; 26(4):391-2. PubMed ID: 11101828
[No Abstract] [Full Text] [Related]
10. Comparative analysis of p73 and p53 regulation and effector functions.
Fang L; Lee SW; Aaronson SA
J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
[TBL] [Abstract][Full Text] [Related]
12. p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints.
Wang S; El-Deiry WS
Cancer Res; 2006 Jul; 66(14):6982-9. PubMed ID: 16849542
[TBL] [Abstract][Full Text] [Related]
13. P53-independent downregulation of p73 in human cancer cells treated with Adriamycin.
Yuan R; Meng Q; Hu H; Goldberg ID; Rosen EM; Fan S
Cancer Chemother Pharmacol; 2001; 47(2):161-9. PubMed ID: 11269743
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis.
Choi HR; Batsakis JG; Zhan F; Sturgis E; Luna MA; El-Naggar AK
Hum Pathol; 2002 Feb; 33(2):158-64. PubMed ID: 11957139
[TBL] [Abstract][Full Text] [Related]
15. The emerging p53 gene family.
Kaelin WG
J Natl Cancer Inst; 1999 Apr; 91(7):594-8. PubMed ID: 10203277
[TBL] [Abstract][Full Text] [Related]
16. The p53 gene family.
Kaelin WG
Oncogene; 1999 Dec; 18(53):7701-5. PubMed ID: 10618710
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins.
Roth J; König C; Wienzek S; Weigel S; Ristea S; Dobbelstein M
J Virol; 1998 Nov; 72(11):8510-6. PubMed ID: 9765388
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
Aoki T; Miyamoto A; Marubashi S; Nagano H; Umeshita K; Fujiwara Y; Dono K; Nakamori S; Sakon M; Monden M
Int J Oncol; 2004 Feb; 24(2):441-6. PubMed ID: 14719122
[TBL] [Abstract][Full Text] [Related]
19. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.
Vikhanskaya F; D'Incalci M; Broggini M
Nucleic Acids Res; 2000 Jan; 28(2):513-9. PubMed ID: 10606650
[TBL] [Abstract][Full Text] [Related]
20. Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.
Nicholson SA; Okby NT; Khan MA; Welsh JA; McMenamin MG; Travis WD; Jett JR; Tazelaar HD; Trastek V; Pairolero PC; Corn PG; Herman JG; Liotta LA; Caporaso NE; Harris CC
Cancer Res; 2001 Jul; 61(14):5636-43. PubMed ID: 11454718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
